Tumors of the chest : biology, diagnosis, and management

Cover......Page 1
Contents\r......Page 13
1 Epidemiology of Lung Cancer\r......Page 23
2 Screening Problems for Lung Cancer\r......Page 33
3 Biology of Tobacco and Smoking\r......Page 43
4 Laboratory Models of Lung Cancer\r......Page 61
5 Genetics of Lung Cancer\r......Page 75
6 Molecular Biology of Lung Cancer\r......Page 85
7 Preneoplastic Lesions of the Lung\r......Page 99
8 Pathology of Lung Cancer\r......Page 110
9 Clinical Presentation of Lung Cancer\r......Page 124
10 The Role of Bronchoscopy and the Diagnosis and Staging of Lung Cancer\r......Page 136
11 Radiological Diagnosis and Stagong of Lung Cancer\r......Page 141
12 Surgical Stagong of NSCLC\r......Page 159
13 Molecular Staging of NSCLC\r......Page 172
14 Clinical Prognostic Factors in NSCLC\r......Page 190
15 Prognostic Factors in SCLC\r......Page 201
16 Surgical Management of Localized and Locally Advanced NSCLC\r......Page 211
17 Radical Radiotherapy in the Management of Locally Advanced NSCLC\r......Page 233
18 Palliative Radiotherapy in the Management of NSCLC\r......Page 243
19 Integration of Radiotherapy in the Management of Locally Advanced NSCLC\r......Page 247
20 Integration of Chemotherapy in the Management of Locally Advanced NSCLC\r......Page 258
21 Integration of Biological Therapies in Locally Advanced NSCLC\r......Page 270
22 Platinm Based Chemotherapy for Advanced NSCLC\r......Page 281
23 Non Platinum Based Chemotherpay for Advanced NSCLC\r......Page 297
24 Second Line Chemotherpay for NSCLC\r......Page 312
25 Management of Patiens with Advanced NSCLC and Performance Status 2\r......Page 322
26 Targeted Therapy of NSCLC\r......Page 327
27 Management of Cerebral Metastasis in Patients with NSCLC\r......Page 341
28 Management of NSCLC in the Elderly\r......Page 349
29 Management of Limited Disease SCLC\r......Page 359
30 Management of Extensive SCLC\r......Page 374
31 Management of Relapsed SCLC\r......Page 380
32 Prophylactic Cranial Iradiation in Patients with SCLC\r......Page 386
33 Late Effects of SCLC Treatment\r......Page 392
34 Novel Cytotoxic Agents in the Management of SCLC\r......Page 404
35 Novel Targets for Lung Cancer Therapy\r......Page 419
36 Gene Therapy for Lung Cancer\r......Page 430
37 NSCLC:\r Clinical Studies in Europe......Page 438
38 North American Cooperative Group Research Efforts in Lung Cancer\r......Page 450
39 Clinical Trials for Lung Cancer in Progress in Japan\r......Page 461
40 Epidemiology and Etiology of Mesothelioma\r......Page 469
41 Molecular Epidemiology and Biology of Mesothelioma\r......Page 477
42 Pathology of Malignant Mesothelioma\r......Page 488
43 Surgical Management of Mesothelioma\r......Page 497
44 The Role of Chemotherapy in the Management of Mesothelioma\r......Page 508
45 Rare Tumors of the Chest\r......Page 518
46 Quality of Life after Cancer Surgery\r......Page 528
47 Pain Management in Palliative Care\r......Page 536
48 Pathophysiology and Management of Bone Metastases in Lung Cancer\r......Page 542
49 Managemtn of Malignant Pleural Effusions\r......Page 554
50 Palliation of Dyspnea in the Terminally Ill Patient with Lung Cancer\r......Page 565
51 Endobronchial Treatment of Lung Cancer\r......Page 570
52 Delivering Bad News to Patients and Their Families\r......Page 585
53 Chemoprevention of Lung Cancer\r......Page 595
54 Smoking Prevention and Cessation Policies\r......Page 613
55 Cost Effectiveness of Smoking Cessation Interventions\r......Page 626
56 Financial Aspects of Lung Cancer\r......Page 634
57 Decision Making in Lung Cancer\r......Page 645
Subject Index\r......Page 662